News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

Oxford University Covid-19 vaccine shows strong immune response in adults

Mid-stage tests for the Oxford University-AstraZeneca coronavirus vaccine show 'encouraging' results

The Oxford University coronavirus vaccine has shown a strong immune response in older adults, the most at-risk age group for Covid-19.

In mid-stage trial results published in the medical journal Lancet, researchers say the results for adults in their 60s and 70s are “encouraging”.

WSJ Logo